Research Article
Intratumoral Heterogeneity Determines the Expression of mTOR-pathway Proteins in Prostate Cancer
Table 1
Baseline characteristics of the patients.
| | Number of patients | |
| | Age, median (IQR) | 65.0 (60.0-69.0) | | PSA, median (IQR) | 9.0 (5.3-12.9) | | Clinical lymph node metastasis, (%) | 5 (4.3) | | Bilateral disease, (%) | 92 (80.0) | | Pathological T stage, (%) | | | T2 | 78 (67.8) | | T3a | 17 (14.8) | | T3b | 20 (17.4) | | Pathological Gleason score, (%) | | | 6 | 62 (53.9) | | 7 | 45 (39.1) | | 8-10 | 8 (7.0) | | Perineural invasion, (%) | 33 (28.7) | | Positive margins, (%) | 25 (21.7) |
|
|
IQR = interquartile range; PSA = prostate-specific antigen.
|
